Integrating educational and technological interventions to improve pregnancy outcomes in women with diabetes

Diabetes, Obesity and Metabolism

Volumn 12, Issue 2, 2010, Pages 97-104

  Murphy, Helen R ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Diabetes; Education; Pregnancy; Technology

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN; INSULIN DERIVATIVE;

BLOOD GLUCOSE MONITORING; CONTINUOUS INFUSION; DIET; DRUG EFFICACY; EDUCATION PROGRAM; EMPOWERMENT; EXERCISE; GLYCEMIC CONTROL; HEALTH CARE ACCESS; HEALTH CARE COST; HIGH RISK PATIENT; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PUMP; MACROSOMIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PREECLAMPSIA; PREGNANCY DIABETES MELLITUS; PREGNANCY OUTCOME; PRENATAL CARE; REVIEW; SELF CARE; SELF CONCEPT;

EID: 73349084319     PISSN: 14628902     EISSN: 14631326     Source Type: Journal    
DOI: 10.1111/j.1463-1326.2009.01145.x     Document Type: Review

References (70)

1. Johnstone FD, Lindsay RS, Steel J. Type 1 diabetes and pregnancy: trends in birth weight over 40 years at a single clinic. Obstet Gynecol 2006, 107:1297-1302.
2. Diabetes care and research in Europe: the Saint Vincent declaration. Diabet Med 1990, 7:360.
3. Macintosh MC, Fleming KM, Bailey JA. Perinatal mortality and congenital anomalies in babies of women with type 1 or type 2 diabetes in England, Wales, and Northern Ireland: population based study. BMJ 2006, 333:177.
4. Evers IM, de Valk HW, Visser GH. Risk of complications of pregnancy in women with type 1 diabetes: nationwide prospective study in the Netherlands. BMJ 2004, 328:915.
5. Mills JL, Knopp RH, Simpson JL. Lack of relation of increased malformation rates in infants of diabetic mothers to glycemic control during organogenesis. N Engl J Med 1988, 318:671-676.
6. Fuhrmann K, Reiher H, Semmler K, Fischer F, Fischer M, Glockner E. Prevention of congenital malformations in infants of insulin-dependent diabetic mothers. Diabetes Care 1983, 6:219-223.
7. Fuhrmann K, Reiher H, Semmler K, Glockner E. The effect of intensified conventional insulin therapy before and during pregnancy on the malformation rate in offspring of diabetic mothers. Exp Clin Endocrinol 1984, 83:173-177.
8. Jensen BM, Kuhl C, Molsted-Pedersen L, Saurbrey N, Fog-Pedersen J. Preconceptional treatment with insulin infusion pumps in insulin-dependent diabetic women with particular reference to prevention of congenital malformations. Acta Endocrinol Suppl (Copenh) 1986, 277:81-85.
9. Goldman JA, Dicker D, Feldberg D, Yeshaya A, Samuel N, Karp M. Pregnancy outcome in patients with insulin-dependent diabetes mellitus with preconceptional diabetic control: a comparative study. Am J Obstet Gynecol 1986, 155:293-297.
10. Rowe BR, Rowbotham CJ, Barnett AH. Pre-conception counselling, birth weight, and congenital abnormalities in established and gestational diabetic pregnancy. Diabetes Res 1987, 6:33-35.
11. Damm P, Molsted-Pedersen L. Significant decrease in congenital malformations in newborn infants of an unselected population of diabetic women. Am J Obstet Gynecol 1989, 161:1163-1167.
12. Steel JM, Johnstone FD, Hepburn DA, Smith AF. Can prepregnancy care of diabetic women reduce the risk of abnormal babies? BMJ 1990, 301:1070-1074.
13. Kitzmiller JL, Gavin LA, Gin GD, Jovanovic-Peterson L, Main EK, Zigrang WD. Preconception care of diabetes. Glycemic control prevents congenital anomalies. JAMA 1991, 265:731-736.
14. Willhoite MB, Bennert HW. The impact of preconception counseling on pregnancy outcomes. The experience of the Maine Diabetes in Pregnancy Program. Diabetes Care 1993, 16:450-455.
15. Cousins L, Kitzmiller J, Schneider J. The California Diabetes and Pregnancy Program: implementation of a multicenter experience with diabetic pregnancies. J Perinatol 1992, 12:173-180.
16. Temple RC, Aldridge V, Murphy HR. Prepregnancy care and pregnancy outcomes in women with type 1 diabetes. Diabetes Care 2006, 29:1744-1749.
17. Pregnancy in Women with Type 1 and Type 2 Diabetes in 2002-03, England, Wales and Northern Ireland. 2005, Confidential Enquiry into Maternal and Child Health, London, CEMACH
18. McElduff A, Ross GP, Lagstrom JA, Champion B, Flack JR, Lau SM. Pregestational diabetes and pregnancy: an Australian experience. Diabetes Care 2005, 28:1260-1261.
19. Dunstan DW, Zimmet PZ, Welborn TA. The rising prevalence of diabetes and impaired glucose tolerance: the Australian Diabetes, Obesity and Lifestyle Study. Diabetes Care 2002, 25:829-834.
20. Ball V, Roland JM, Temple RC, Murphy HR. Interim results from the East Anglia Regional Prepregnancy Care Programme. Diabet Med 2009, 26(Suppl 1):178.
21. Hillman N, Herranz L, Vaquero PM, Villarroel A, Fernandez A, Pallardo LF. Is pregnancy outcome worse in type 2 than in type 1 diabetic women? Diabetes Care 2006, 29:2557-2558.
22. Feig DS, Palda VA. Type 2 diabetes in pregnancy: a growing concern. Lancet 2002, 359:1690-1692.
23. Clausen TD, Mathiesen E, Ekbom P, Hellmuth E, Mandrup-Poulsen T, Damm P. Poor pregnancy outcome in women with type 2 diabetes. Diabetes Care 2005, 28:323-328.
24. Roland JM, Murphy HR, Ball V, Northcote-Wright J, Temple RC. The pregnancies of women with Type 2 diabetes: poor outcomes but opportunities for improvement. Diabet Med 2005, 22:1774-1777.
25. Cundy T, Gamble G, Townend K, Henley PG, MacPherson P, Roberts AB. Perinatal mortality in Type 2 diabetes mellitus. Diabet Med 2000, 17:33-39.
26. Boulot P, Chabbert-Buffet N, d'Ercole C. French multicentric survey of outcome of pregnancy in women with pregestational diabetes. Diabetes Care 2003, 26:2990-2993.
27. Dunne F. Type 2 diabetes and pregnancy. Semin Fetal Neonatal Med 2005, 10:333-339.
28. Diabetes in Pregnancy: Are we providing the best care? Findings of a National Enquiry: England, Wales and Northern Ireland. 2007, Confidential Enquiry into Maternal and Child Health, London, CEMACH
29. Murphy HR, Rayman G, Lewis K. Effectiveness of continuous glucose monitoring in pregnant women with diabetes: randomised clinical trial. BMJ 2008, 337:a1680.
30. Temple RC, Aldridge VJ, Murphy HR. Prepregnancy care and pregnancy outcomes in women with type 1 diabetes. Diabetes Care 2006, 29:1744-1749.
31. Management of diabetes and its complications in pregnancy from the pre-conception to the postnatal period. 2008, www.nice.org, NICE guideline 63: Diabetes in Pregnancy
32. Nielsen LR, Ekbom P, Damm P. HbA1c levels are significantly lower in early and late pregnancy. Diabetes Care 2004, 27:1200-1201.
33. Temple RC, Aldridge V, Stanley K, Murphy HR. Glycaemic control throughout pregnancy and risk of pre-eclampsia in women with type I diabetes. BJOG 2006, 113:1329-1332.
34. Evers IM, de Valk HW, Mol BW, ter Braak EW, Visser GH. Macrosomia despite good glycaemic control in Type I diabetic pregnancy; results of a nationwide study in The Netherlands. Diabetologia 2002, 45:1484-1289.
35. Holing EV, Beyer CS, Brown ZA, Connell FA. Why don't women with diabetes plan their pregnancies? Diabetes Care 1998, 21:889-895.
36. Knowledge about preconception care in French women with type 1 diabetes. Diabetes Metab 2005, 31:443-447. Diabetes and Pregnancy Study Group
37. Murphy HR, Temple RC, Ball V, Zill-E-Huma R, Roland JM, Skinner TC. Barriers to attending prepregnancy care in women with diabetes. Diabet Med 2009, 26(Suppl 1):177.
38. Griffiths F, Lowe P, Boardman F, Ayre C, Gadsby R. Becoming pregnant: exploring the perspectives of women living with diabetes. Br J Gen Pract 2008, 58:184-190.
39. Howorka K, Pumprla J, Gabriel M. Normalization of pregnancy outcome in pregestational diabetes through functional insulin treatment and modular out-patient education adapted for pregnancy. Diabet Med 2001, 18:965-972.
40. de Veciana M, Major CA, Morgan MA. Postprandial versus preprandial blood glucose monitoring in women with gestational diabetes mellitus requiring insulin therapy. N Engl J Med 1995, 333:1237-1241.
41. Homko CJ, Sivan E, Reece EA. The impact of self-monitoring of blood glucose on self-efficacy and pregnancy outcomes in women with diet-controlled gestational diabetes. Diabetes Educ 2002, 28:435-443.
42. Training in flexible, intensive insulin management to enable dietary freedom in people with type 1 diabetes: dose adjustment for normal eating (DAFNE) randomised controlled trial. BMJ 2002, 325:746.
43. Deakin TA, Cade JE, Williams R, Greenwood DC. Structured patient education: the diabetes X-PERT Programme makes a difference. Diabet Med 2006, 23:944-954.
44. Davies MJ, Heller S, Skinner TC. Effectiveness of the diabetes education and self management for ongoing and newly diagnosed (DESMOND) programme for people with newly diagnosed type 2 diabetes: cluster randomised controlled trial. BMJ 2008, 336:491-495.
45. Hawthorne K, Robles Y, Cannings-John R, Edwards AG. Culturally appropriate health education for type 2 diabetes mellitus in ethnic minority groups. Cochrane Database Syst Rev 2008, 3:CD006424.
46. Anderson RM, Funnell MM. Patient empowerment: reflections on the challenge of fostering the adoption of a new paradigm. Patient Educ Couns 2005, 57:153-157.
47. Anderson RM, Funnell MM, Butler PM, Arnold MS, Fitzgerald JT, Feste CC. Patient empowerment. Results of a randomized controlled trial. Diabetes Care 1995, 18:943-949.
48. Thorsell A, Gordon M, Jovanovic L. Continuous glucose monitoring: a stepping stone in the journey towards a cure for diabetes. J Matern Fetal Neonatal Med 2004, 15:15-25.
49. Klonoff DC. Continuous glucose monitoring: roadmap for 21st century diabetes therapy. Diabetes Care 2005, 28:1231-1239.
50. Yogev Y, Ben-Haroush A, Chen R, Rosenn B, Hod M, Langer O. Diurnal glycemic profile in obese and normal weight nondiabetic pregnant women. Am J Obstet Gynecol 2004, 191:949-953.
51. Yogev Y, Chen R, Ben-Haroush A, Phillip M, Jovanovic L, Hod M. Continuous glucose monitoring for the evaluation of gravid women with type 1 diabetes mellitus. Obstet Gynecol 2003, 101:633-638.
52. Yogev Y, Ben-Haroush A, Chen R, Kaplan B, Phillip M, Hod M. Continuous glucose monitoring for treatment adjustment in diabetic pregnancies-a pilot study. Diabet Med 2003, 20:558-562.
53. Kerssen A, de Valk HW, Visser GH. Day-to-day glucose variability during pregnancy in women with Type 1 diabetes mellitus: glucose profiles measured with the Continuous Glucose Monitoring System. BJOG 2004, 111:919-924.
54. Kerssen A, de Valk HW, Visser GH. Forty-eight-hour first-trimester glucose profiles in women with type 1 diabetes mellitus: a report of three cases of congenital malformation. Prenat Diagn 2006, 26:123-127.
55. Kerssen A, de Valk HW, Visser GH. Do HbA(1)c levels and the self-monitoring of blood glucose levels adequately reflect glycaemic control during pregnancy in women with type 1 diabetes mellitus? Diabetologia 2006, 49:25-28.
56. Kerssen A, Evers IM, de Valk HW, Visser GH. Poor glucose control in women with type 1 diabetes mellitus and 'safe' hemoglobin A1c values in the first trimester of pregnancy. J Matern Fetal Neonatal Med 2003, 13:309-313.
57. Murphy HR, Rayman G, Duffield K. Changes in the glycemic profiles of women with type 1 and type 2 diabetes during pregnancy. Diabetes Care 2007, 30:2785-2791.
58. Murphy HR, Rayman G, Lewis K. Post-prandial hyperglycaemia during pregnancy in women with type 1 diabetes. Diabet Med 2009, 26:75.
59. Herranz L, Pallardo LF, Hillman N, Martin-Vaquero P, Villarroel A, Fernandez A. Maternal third trimester hyperglycaemic excursions predict large-for-gestational-age infants in type 1 diabetic pregnancy. Diabetes Res Clin Pract 2007, 75:42-46.
60. Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med 2008, 359(14):1464-1476. Tamborlane WV, Beck RW, Bode BW, Buckingham B, Chase HP, Clemons R
61. Gabbe SG, Holing E, Temple P, Brown ZA. Benefits, risks, costs, and patient satisfaction associated with insulin pump therapy for the pregnancy complicated by type 1 diabetes mellitus. Am J Obstet Gynecol 2000, 182:1283-1291.
62. Mukhopadhyay A, Farrell T, Fraser RB, Ola B. Continuous subcutaneous insulin infusion vs intensive conventional insulin therapy in pregnant diabetic women: a systematic review and metaanalysis of randomized, controlled trials. Am J Obstet Gynecol 2007, 197(5):447-456.
63. Chen R, Ben-Haroush A, Weissman-Brenner A, Melamed N, Hod M, Yogev Y. Level of glycemic control and pregnancy outcome in type 1 diabetes: a comparison between multiple daily insulin injections and continuous subcutaneous insulin infusions. Am J Obstet Gynecol 2007, 197:404.e1-404.e5.
64. Farrar D, Tuffnell DJ, West J. Continuous subcutaneous insulin infusion versus multiple daily injections of insulin for pregnant women with diabetes. Cochrane Database Syst Rev 2007, 3:CD005542.
65. Hammond PJ, Ray S, Carling J. An audit of pregnancy outcomes in type 1 diabetes comparing continuous subcuataneous insulin infusion with multiple daily injections. Diabetologia 2008, 51(Suppl 1):S458.
66. Hebda-Szydlo A, Cyganek K, Malecki MT. The efficacy of continuous subcutaneous insulin infusion and multiple daily injections in women with type 1 diabetes. Diabetologia 2008, 51(Suppl 1):S456.
67. Pancani F, Lencioni C, Aragona M. Continuous subcutaneous insulin infusion and multiple dose insulin injection in type 1 diabetic pregnant women: a case control study. Diabetologia 2008, 51(Suppl 1):S457.
68. Hovorka R. Continuous glucose monitoring and closed-loop systems. Diabet Med 2006, 23:1-12.
69. Hovorka R, Acerini CL, Allen J. Overnight sc-sc Closed loop control improves glucose control and reduces risks of hypoglycaemia in children and adolescents with type 1 diabetes. Diabetes 2008, 57:A22-A22.
70. Hovorka R, Acerini CL, Allen J. Good overnight closed-loop glucose control in children and adolescents with type 1 diabetes following ingestion of large, rapidly and slowly absorbed evening meal. Diabetologia 2008, 51:181.